PI
IMCR icon

PEAK6 Investments’s Immunocore IMCR Stock Holding History

PEAK6 Investments’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$46.7K Hold
1,500
– – ﹤0.01% 3118
2024
Q2 		$50.8K Buy
+1,500
New +$76.5K ﹤0.01% 3157

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

PEAK6 Investments's IMCR Position: Q3 2024 in Review

PEAK6 Investments held its Immunocore (IMCR) position steady in Q3 2024 at 1,500 shares worth $46.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3118.

PEAK6 Investments first reported a position in IMCR in Q2 2024 and has held it in 2 quarters since. The position peaked at $50.8K in Q2 2024. 130 funds tracked by Wall St. Rank hold IMCR as of Q3 2024.

  • PEAK6 Investments held 1,500 shares of Immunocore worth $46.7K as of Q3 2024.
  • PEAK6 Investments left its Immunocore share count unchanged in Q3 2024.
  • Immunocore made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3118 holding.
  • PEAK6 Investments first reported a position in Immunocore in Q2 2024 and has held it in 2 quarters since.
  • PEAK6 Investments's Immunocore position peaked at $50.8K in Q2 2024.
  • 130 funds tracked by Wall St. Rank held Immunocore as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.